Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034236
Filing Date
2024-11-08
Accepted
2024-11-08 17:09:38
Documents
54
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20240930d_10q.htm   iXBRL 10-Q 916686
2 EXHIBIT 31.1 ex_721362.htm EX-31.1 13468
3 EXHIBIT 31.2 ex_721363.htm EX-31.2 13184
4 EXHIBIT 32.1 ex_721364.htm EX-32.1 6747
5 EXHIBIT 32.2 ex_721365.htm EX-32.2 6826
11 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-24-034236.txt   4208816

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240930.xsd EX-101.SCH 43333
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20240930_cal.xml EX-101.CAL 25431
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240930_def.xml EX-101.DEF 262120
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240930_lab.xml EX-101.LAB 241802
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240930_pre.xml EX-101.PRE 284037
57 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240930d_10q_htm.xml XML 553892
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 241441729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)